Published in Hepatitis Weekly, May 7th, 2001
Reporting at the 36th annual meeting of the European Association for the Study of the Liver (EASL), held April 18-22, 2001, in Prague, Czech Republic, P. Pradat and colleagues, Hotel-Dieu, Lyon, France, said that it actually may benefit this group most to undergo liver biopsy.
The title of the Pradat et al. study is "Predictive value of ALT levels on histological findings in chronic hepatitis C: A European collaborative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-05-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.